Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes

Mai Shi; Aimin Yang; Elaine Chow; Eric S H Lau; Claudia H T Tam; Alice P S Kong; Andrea O Y Luk; Ronald C W Ma; Christina M T Cheung; Juliana C N Chan; Agnes W S Chan

doi:10.1111/jdv.18762

Genetic susceptibility of dipeptidyl Peptidase-4 inhibitor associated bullous pemphigoid in Chinese patients with type 2 diabetes

J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e375-e377. doi: 10.1111/jdv.18762. Epub 2022 Nov 25.

Authors

Mai Shi^{1

2}, Aimin Yang^{1

2}, Elaine Chow^{1

3}, Eric S H Lau^{1

2}, Claudia H T Tam^{1

2}, Alice P S Kong^{1

2

4}, Andrea O Y Luk^{1

2

4}, Ronald C W Ma^{1

2

4}, Christina M T Cheung¹, Juliana C N Chan^{1

3

4}, Agnes W S Chan¹

Affiliations

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
² Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong.
³ Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Shatin, Hong Kong.
⁴ Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Shatin, Hong Kong.

PMID: 36394174
DOI: 10.1111/jdv.18762

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
East Asian People
Genetic Predisposition to Disease
Humans
Pemphigoid, Bullous* / chemically induced
Pemphigoid, Bullous* / genetics

Substances

Dipeptidyl-Peptidase IV Inhibitors

Publication types

MeSH terms

Substances

Grants and funding